BPMX - BioPharmX Corporation

NYSE American - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue1/31/20191/31/20181/31/20171/31/2016
Total Revenue577310064
Cost of Revenue83250427237
Gross Profit-26-177-327-173
Operating Expenses
Research Development8,4938,5289,7245,345
Selling General and Administrative7,754.58,1718,2869,640
Non Recurring----
Others----
Total Operating Expenses16,330.516,94918,43715,222
Operating Income or Loss-16,273.5-16,876-18,337-15,158
Income from Continuing Operations
Total Other Income/Expenses Net-982.5263-67-436
Earnings Before Interest and Taxes-16,273.5-16,876-18,337-15,158
Interest Expense---141-141
Income Before Tax-17,256-16,638-18,404-15,594
Income Tax Expense2224
Minority Interest----
Net Income From Continuing Ops-17,258-16,640-18,406-15,598
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-17,258-16,640-18,406-15,598
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-17,258-16,640-18,532-16,001